UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

Proceedings of the National Academy of Sciences - PNAS, 2012-01, Vol.109 (1), p.261-266

2012

Volltextzugriff (PDF)

Gaussian prepivoting for finite population causal inference

Journal of the Royal Statistical Society. Series B, Statistical methodology, 2022-04, Vol.84 (2), p.295-320

2022

Volltextzugriff (PDF)

Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained

Cancer research (Chicago, Ill.), 2010-05, Vol.70 (9), p.3526-3536

2010

Volltextzugriff (PDF)

MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy

International immunopharmacology, 2011-07, Vol.11 (7), p.856-861

2011

Volltextzugriff (PDF)

Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

Clinical cancer research, 2009-03, Vol.15 (6), p.2148-2157

2009

Volltextzugriff (PDF)

Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide

Chemical communications (Cambridge, England), 2015-01, Vol.51 (50), p.10214-10217

2015

Volltextzugriff (PDF)

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice

PloS one, 2016-01, Vol.11 (1), p.e0145920-e0145920

2016

Volltextzugriff (PDF)

The Limited Relevance of Drug Policy: Cannabis in Amsterdam and in San Francisco

American journal of public health (1971), 2004-05, Vol.94 (5), p.836-842

2004

Volltextzugriff (PDF)

Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challenges

Cancer research (Chicago, Ill.), 2014-12, Vol.74 (23), p.6845-6855

2014

Volltextzugriff (PDF)

Tumor-Induced CD11b+Gr-1+ Myeloid Cells Suppress T Cell Sensitization in Tumor-Draining Lymph Nodes

The Journal of immunology (1950), 2008-09, Vol.181 (5), p.3291-3300

2008

Volltextzugriff (PDF)

Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment

Oncoimmunology, 2017-06, Vol.6 (6), p.e1322238-e1322238

2017

Volltextzugriff (PDF)

Sunitinib facilitates the activation and recruitment of therapeutic anti‐tumor immunity in concert with specific vaccination

International journal of cancer, 2011-11, Vol.129 (9), p.2158-2170

2011

Volltextzugriff (PDF)

Medical Marijuana 2010: It's Time to Fix the Regulatory Vacuum

The Journal of law, medicine & ethics, 2010-09, Vol.38 (3), p.654-666

Cohen, Peter J.

2010

Volltextzugriff (PDF)

Immune and Anticancer Responses Elicited by Fully Synthetic Aberrantly Glycosylated MUC1 Tripartite Vaccines Modified by a TLR2 or TLR9 Agonist

Chembiochem : a European journal of chemical biology, 2014-07, Vol.15 (10), p.1508-1513

2014

Volltextzugriff (PDF)

Combination of sunitinib with anti‐tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy

International journal of cancer, 2014-04, Vol.134 (7), p.1695-1705

2014

Volltextzugriff (PDF)

66.4 Elie Wiesel and the Developmental Role of Expressed Memory as an Antidote to Indifference

Journal of the American Academy of Child and Adolescent Psychiatry, 2024-10, Vol.63 (10), p.S93-S93

Cohen, Peter R.

2024

Volltextzugriff (PDF)

International Stem Cell Tourism and the Need for Effective Regulation: Part I: Stem Cell Tourism in Russia and India: Clinical Research, Innovative Treatment, or Unproven Hype?

Kennedy Institute of Ethics journal, 2010-03, Vol.20 (1), p.27-49

2010

Volltextzugriff (PDF)

Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17

PloS one, 2013-01, Vol.8 (1), p.e54804

2013

Volltextzugriff (PDF)

A Randomized Phase 2 Study of Temozolomide and Bevacizumab or nab-Paclitaxel, Carboplatin, and Bevacizumab in Patients With Unresectable Stage IV Melanoma: A North Central Cancer Treatment Group Study, N0775

Cancer, 2013-02, Vol.119 (3), p.586-592

2013

Volltextzugriff (PDF)

Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337)

Clinical cancer research, 2015-12, Vol.21 (24), p.5445-5452

2015

Volltextzugriff (PDF)

A phase I dose-finding study of the novel Toll-like receptor 8 agonist VTX-2337 in adult subjects with advanced solid tumors or lymphoma

Clinical cancer research, 2014-07, Vol.20 (14), p.3683-3691

2014

Volltextzugriff (PDF)

Multipeptide stimulated PBMCs generate TEM/TCM for adoptive cell therapy in multiple myeloma

Oncotarget, 2021-09, Vol.12 (20), p.2051-2067

2021

Volltextzugriff (PDF)

57.3 Learning How to Lead: From Cradle to Community

Journal of the American Academy of Child and Adolescent Psychiatry, 2023-10, Vol.62 (10), p.S84-S84

Cohen, Peter R.

2023

Volltextzugriff (PDF)

Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion

Cancer research (Chicago, Ill.), 2007-02, Vol.67 (4), p.1842-1852

2007

Volltextzugriff (PDF)

1 – 25 von 8.261

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.591)
Mit Volltextzugriff
(6.732)

Publikationsform

9 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(4.513)
Life Sciences & Biomedicine
(3.828)
Humans
(3.210)
Female
(1.819)
Male
(1.757)
Biological And Medical Sciences
(1.158)
Middle Aged
(1.154)
Adult
(1.140)
Medical Sciences
(996)
Aged
(866)
Animals
(608)
Adolescent
(437)
Treatment Outcome
(429)
Physical Sciences
(405)
Cardiovascular System & Cardiology
(404)
General & Internal Medicine
(404)
Neurosciences & Neurology
(394)
Child
(378)
Surgery
(356)
Cardiac & Cardiovascular Systems
(339)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Macworld
(348)
Blood
(121)
The New England Journal Of Medicine
(90)
Journal Of Clinical Oncology
(89)
Neurology
(87)
Journal Of The American College Of Cardiology
(86)
Circulation
(79)
Plos One
(79)
Anesthesiology
(71)
Gastroenterology
(59)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

Gaussian prepivoting for finite population causal inference

Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained

MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy

Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide

Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice

The Limited Relevance of Drug Policy: Cannabis in Amsterdam and in San Francisco

Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challenges

Tumor-Induced CD11b+Gr-1+ Myeloid Cells Suppress T Cell Sensitization in Tumor-Draining Lymph Nodes

Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment

Sunitinib facilitates the activation and recruitment of therapeutic anti‐tumor immunity in concert with specific vaccination

Medical Marijuana 2010: It's Time to Fix the Regulatory Vacuum

Immune and Anticancer Responses Elicited by Fully Synthetic Aberrantly Glycosylated MUC1 Tripartite Vaccines Modified by a TLR2 or TLR9 Agonist

Combination of sunitinib with anti‐tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy

66.4 Elie Wiesel and the Developmental Role of Expressed Memory as an Antidote to Indifference

International Stem Cell Tourism and the Need for Effective Regulation: Part I: Stem Cell Tourism in Russia and India: Clinical Research, Innovative Treatment, or Unproven Hype?

Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17

A Randomized Phase 2 Study of Temozolomide and Bevacizumab or nab-Paclitaxel, Carboplatin, and Bevacizumab in Patients With Unresectable Stage IV Melanoma: A North Central Cancer Treatment Group Study, N0775

Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337)

A phase I dose-finding study of the novel Toll-like receptor 8 agonist VTX-2337 in adult subjects with advanced solid tumors or lymphoma

Multipeptide stimulated PBMCs generate TEM/TCM for adoptive cell therapy in multiple myeloma

57.3 Learning How to Lead: From Cradle to Community

Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion

Suchergebnisse filtern